1. Home
  2. BSX vs UBS Comparison

BSX vs UBS Comparison

Compare BSX & UBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Boston Scientific Corporation

BSX

Boston Scientific Corporation

HOLD

Current Price

$97.46

Market Cap

149.7B

Sector

Health Care

ML Signal

HOLD

Logo UBS Group AG Registered

UBS

UBS Group AG Registered

HOLD

Current Price

$40.73

Market Cap

120.6B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
BSX
UBS
Founded
1979
1862
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
149.7B
120.6B
IPO Year
1992
N/A

Fundamental Metrics

Financial Performance
Metric
BSX
UBS
Price
$97.46
$40.73
Analyst Decision
Strong Buy
Buy
Analyst Count
19
3
Target Price
$124.53
N/A
AVG Volume (30 Days)
8.9M
1.8M
Earning Date
10-22-2025
10-29-2025
Dividend Yield
N/A
1.83%
EPS Growth
54.68
84.33
EPS
1.87
2.21
Revenue
$19,349,000,000.00
$48,193,000,000.00
Revenue This Year
$21.05
$4.87
Revenue Next Year
$11.43
$3.54
P/E Ratio
$52.15
$17.47
Revenue Growth
21.61
2.09
52 Week Low
$85.98
$25.75
52 Week High
$109.50
$42.57

Technical Indicators

Market Signals
Indicator
BSX
UBS
Relative Strength Index (RSI) 41.77 66.47
Support Level $100.50 $38.33
Resistance Level $101.91 $38.27
Average True Range (ATR) 2.03 0.57
MACD -0.30 0.29
Stochastic Oscillator 19.87 96.66

Price Performance

Historical Comparison
BSX
UBS

About BSX Boston Scientific Corporation

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.

About UBS UBS Group AG Registered

UBS is a global financial institution built around its core strength in wealth management, serving high and ultra-high-net-worth individuals. In Switzerland, it also operates as a traditional retail and commercial bank. Its investment bank and asset management divisions complement the wealth business, providing tailored solutions to UBS clients while serving third-party customers by leveraging UBS' global reach and expertise.

Share on Social Networks: